The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Peripheral myeloid cells as prognostic markers in patients (pts) with non-small cell lung cancer (NSCLC) treated with cemiplimab: Pooled analysis of EMPOWER-Lung 1 and EMPOWER-Lung 3 phase 3 trials.
 
Joseph Christopher Murray
Honoraria - Janssen
Consulting or Advisory Role - MJH Life Sciences
Research Funding - Merck
 
Debra AG McIntyre
Employment - Regeneron
Stock and Other Ownership Interests - Johnson & Johnson; Regeneron
 
Valsamo Anagnostou
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Delfi Diagnostics (Inst); Personal Genome Diagnostics (Inst)
 
Julie R. Brahmer
Honoraria - Janssen
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Eisai; Genentech; GlaxoSmithKline; Incyte; Merck; Regeneron; Sanofi
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); RAPT Therapeutics (Inst); Spectrum Pharmaceuticals (Inst)
Other Relationship - Bristol-Myers Squibb; Merck; Regeneron
 
Alexander Meisel
Honoraria - Astellas Pharma; GlaxoSmithKline
Consulting or Advisory Role - Boehringer Ingelheim; Gerresheimer; Regeneron; Sanofi
Research Funding - Bayer; Gerresheimer
Travel, Accommodations, Expenses - Takeda
 
Ahmet Sezer
Honoraria - Amgen (Inst); pfizer (Inst); Roche (Inst)
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Pfizer; Roche
Research Funding - Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; REGENERON; Roche
 
Miranda Gogishvili
No Relationships to Disclose
 
Tamar Melkadze
No Relationships to Disclose
 
Ana Baramidze
No Relationships to Disclose
 
Tamta Makharadze
No Relationships to Disclose
 
Adam He
Employment - Regeneron
 
Siyu Li
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Vladimir Jankovic
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Frank A. Seebach
Employment - Regeneron
Leadership - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Petra Rietschel
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Young J. Kim
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Giuseppe Gullo
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Jean-Francois Pouliot
Employment - AstraZeneca; Regeneron
Stock and Other Ownership Interests - Merck; Regeneron